Floatz logo

POLO-LIKE KINASE 1 INHIBITOR NMS-1286937

KRAS Gene Mutation

Cardiff OncologySmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the KRAS Gene Mutation cohort.

Asset / SponsorPhaseRating
gsk1120212
Memorial Sloan Kettering Cancer Center
Phase 2BB
Regorafenib
Stanford University
Phase 2B
METHOTREXATE
Stanford University
Phase 2B
5-azacytidine
Stanford University
Phase 2B
Palbociclib
Calithera Biosciences, Inc
Phase 1/2B

View all 30 →

Same molecule, other indications

POLO-LIKE KINASE 1 INHIBITOR NMS-1286937 is also rated in:

pancreatic ductal adenocarcinomaDormant
B
Indicative ·
60 / 100
View asset →
colorectal cancerDormant
B
Indicative ·
58 / 100
View asset →
malignant pancreatic neoplasmDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →